Edition:
United Kingdom

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

128.41USD
21 Sep 2018
Change (% chg)

$-0.51 (-0.40%)
Prev Close
$128.92
Open
$128.82
Day's High
$129.14
Day's Low
$127.53
Volume
235,278
Avg. Vol
88,424
52-wk High
$132.49
52-wk Low
$96.70

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 29.01 85.68 32.76
EPS (TTM): 3.79 -- --
ROI: 7.94 1.79 14.61
ROE: 20.38 3.28 16.33

BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

May 10 Charles River Laboratories International Inc:

10 May 2018

BRIEF-Charles River Laboratories Reports Q1 Non-GAAP Earnings Per Share Of $1.38

May 10 Charles River Laboratories International Inc:

10 May 2018

BRIEF-Charles River Laboratories CEO's 2017 Total Compensation Was $12.6 Mln

March 29 Charles River Laboratories International Inc:

29 Mar 2018

BRIEF-Charles River Laboratories Announces Offering Of $500 Mln Of Senior Notes

March 26 Charles River Laboratories International Inc:

26 Mar 2018

Earnings vs. Estimates